Product Images Clopidogrel Bisulfate

The text indicates the medicine is Clopidogrel, supplied in the form of tablets of 75mg strength containing 30 tablets in a pack. The NDC code printed on the packaging is 70934-797-30. The rest of the text is not legible and hence the description cannot be generated.*

This is a chart or graph displaying the cumulative event rates of cardiovascular death, myocardial infarction, and stroke in patients who received either placebo (with aspirin) or clopidogrel (with aspirin) over the course of several months of follow-up. The graph shows that patients who received clopidogrel had significantly lower rates of these cardiovascular events compared to those who received only a placebo. It is noted that other standard therapies were also administered to the patients as necessary.*

The text describes a figure that shows the cumulative event rates for death in the COMMIT Study. The study compared the use of placebo and clopidogrel in treating patients with aspirin. The figure shows a 7% proportional risk reduction in death with clopidogrel compared to placebo, and this difference was statistically significant with a p-value of 0.03. The data is represented over a period of 28 days since randomization.*

The text appears to be a comparison between Placebo and Clopidogrel. Both groups had a certain number of events, and a proportional risk of 9% was observed in favor of Clopidogrel. There was also a 7% reduction in death and a lower incidence of re-infarction or stroke before the first discharge. The data was evaluated up to 28 days since randomization.*

This appears to be a table or graph showing the cumulative event rates for fatal or non-fatal vascular events of two medications (Aspirin and Clopidogrel) over a 24-month follow-up period. The y-axis represents the percentage of cumulative event rate, while the x-axis shows the number of months of follow-up. However, without more information, it is difficult to provide a more specific description.*